CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPVF) versus Firefly Neuroscience (NASDAQ:AIFF) Critical Survey

CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPVF) and Firefly Neuroscience (NASDAQ:AIFF) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and profitability.

Valuation & Earnings

This table compares CompuGroup Medical SE & Co. KGaA and Firefly Neuroscience”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CompuGroup Medical SE & Co. KGaA	N/A	N/A	N/A	C$0.56	59.70
Firefly Neuroscience	$1.14 million	15.34	-$19.88 million	($0.63)	-1.78

CompuGroup Medical SE & Co. KGaA has higher earnings, but lower revenue than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than CompuGroup Medical SE & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for CompuGroup Medical SE & Co. KGaA and Firefly Neuroscience, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CompuGroup Medical SE & Co. KGaA	0	0	0	0	0.00
Firefly Neuroscience	1	0	0	0	1.00

Institutional and Insider Ownership

24.3% of CompuGroup Medical SE & Co. KGaA shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 6.9% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares CompuGroup Medical SE & Co. KGaA and Firefly Neuroscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CompuGroup Medical SE & Co. KGaA	N/A	N/A	N/A
Firefly Neuroscience	-565.40%	-94.68%	-73.51%

Summary

CompuGroup Medical SE & Co. KGaA beats Firefly Neuroscience on 6 of the 9 factors compared between the two stocks.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations. The Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; provides software solutions for administration, planning and provision of care in outpatient and inpatient medical facilities; and healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer and Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, patient portals, and mobile apps; and operates telematics infrastructure business, that offers secure links, as well as security solutions for service providers. The Pharmacy Information Systems segment develop and sell administrative and billing related software applications, including procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. The company was founded in 1987 and is headquartered in Koblenz, Germany.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.